INTRODUCTION {#s1}
============

Radiation-induced adaptive response (AR) is a phenomenon manifesting as a priming low-dose-induced resistance to a subsequent challenge exposure at higher doses. Investigations of AR are expected to provide an important scientific basis for radiation risk estimates, protection and practical applications, which are of great interest for both public health and academic research \[[@RRS077C1]\]. AR has been studied for nearly three decades since the *editio princeps* of the concept was introduced into radiation biology \[[@RRS077C2]\] and demonstrated in a variety of *in vitro* and *in vivo* systems \[[@RRS077C3]--[@RRS077C5]\]. Among the documented *in vivo* AR models, the mouse model for rescue from bone marrow death reported by Yonezawa and colleagues \[[@RRS077C3], [@RRS077C6]--[@RRS077C8]\] was repeatedly verified \[[@RRS077C9], [@RRS077C10]\]. This model was originally established by using low linear energy transfer (LET) X-rays for the delivery of both the priming and challenge doses. The underlying mechanism was mainly the induction of radio-resistance by the priming low dose in blood-forming tissues, which rescued the bone marrow from death caused by the challenge high dose exposure. This resulted in a significant decrease in mortality in the 30-day survival test.

We previously showed that AR in this model can be observed when high-LET accelerated heavy ions are used for delivering the challenge dose. A low-LET X-ray-induced AR against the high-LET challenge heavy carbon, neon and silicon ions was successfully demonstrated \[[@RRS077C11], [@RRS077C12]\]. In the present work, residual damage in the hematopoietic system was investigated further in the surviving animals receiving challenge carbon or neon ion irradiations with or without priming irradiations from X-rays. By verifying the residual damage in the hematopoietic system in the mouse survivors from the AR group (receiving both the priming and challenge irradiations) and the non-AR group (receiving only the challenge irradiations), the present investigation aimed to study whether the priming irradiations could relieve the detrimental late effect induced by the challenge irradiations in this mouse model of AR.

MATERIALS AND METHODS {#s2}
=====================

Animals {#s2a}
-------

C57BL/6J Jms strain female mice aged 5 weeks were purchased from SLC, Inc. (Japan). The mice were maintained in a conventional animal facility under a 12-h light/12-h dark photoperiod (lights on from 8:00 a.m. to 8:00 p.m.). Animals were housed in autoclaved cages with sterilized wood chips and allowed free access to standard laboratory chow (MB-1, Funabashi Farm Co., Japan) and acidified water *ad libitum*. Animals were acclimatized to the laboratory conditions for 1 week before use. To avoid possible effects from the developmental condition of the animals, 6-week-old mice with a significantly different body weight (more or less than the mean ± 2 SD) were omitted from this study. On the basis of our previous studies, at least 30 mice in the present study were used in each experimental group, and all experiments were repeated at least once. All experimental protocols involving mice were reviewed and approved (Experimental Animal Research Plan Nos. 07-2023, 08-2023 and 09-2023) by The Institutional Animal Care and Use Committee of the National Institute of Radiological Sciences (NIRS). The experiments were performed in strict accordance with the NIRS *Guidelines for the Care and Use of Laboratory Animals*.

Irradiation {#s2b}
-----------

X-rays were generated with an X-ray machine (Pantak-320S, Shimadzu, Japan) operated at 200 kVp and 20 mA, using a 0.50-mm Al + 0.50-mm Cu filter. An exposure rate meter (AE-1321M, Applied Engineering Inc., Japan) was used for the dosimetry. The dose rate for delivering the priming dose at 0.50 Gy was about 0.30 Gy/min. For high-LET heavy-ion irradiations, a monoenergetic ion beam of carbon particles was generated and accelerated by a synchrotron, the Heavy Ion Medical Accelerator in Chiba (HIMAC), at NIRS, Japan. The beam energy was 290 MeV/nucleon for carbon ions and 400 MeV/nucleon for neon ions, corresponding to average LET values of about 15 keV/μm and 30 keV/μm, respectively. The dose rate was at about 0.70 Gy/min for delivery of a challenge dose at 7.50 Gy for X-rays. The dose rate was at about 1.50 Gy/min for delivery of a challenge dose at 5.75 Gy or 6.50 Gy for carbon ions and at 5.50 Gy for neon ions. The mice were held in acryl containers and were exposed to whole-body irradiation at room temperature.

Mouse model for induction of adaptive response {#s2c}
----------------------------------------------

The mouse AR model for rescue from bone marrow death established by Yonezawa *et al.* \[[@RRS077C8]\] was adopted, verified and confirmed under the experimental conditions in our research facilities and was finally applied to our study. In brief, the efficient priming dose of X-rays was 0.50 Gy. The priming dose and challenge dose were given to mice at postnatal ages of 6 and 8 weeks, respectively. The challenge doses for the heavy carbon ion irradiations depended on the endpoint. A challenge dose of 6.50 Gy was used for verification and confirmation of the experimental conditions ensuring the successful induction of AR with priming low-dose X-rays in combination with the challenge high dose from accelerated carbon ions, and a challenge dose of 5.75 Gy was used to obtain more surviving animals in the 30-day survival test for investigations of residual damage in the hematopoietic system. The challenge dose for the heavy neon ion irradiations was 5.50 Gy.

Biological endpoints {#s2d}
--------------------

### The 30-day survival test {#s2d1}

The number of deaths occurring within the 30-day period after delivery of the challenge dose was recorded. When the priming dose induced a significant suppression of mortality caused by the challenge dose alone, AR was considered to be successfully induced.

### Peripheral blood hemogram {#s2d2}

Animals surviving the 30-day survival test were anesthetized by CO~2~ inhalation, their peripheral blood was collected from a femoral artery, and the animals were killed by cervical dislocation. A differential blood cell count was done using a blood cell differential automatic analyzer (SYSMEX K-4500, Sysmex Corporation, Japan). The data for each experimental group were from at least five mouse survivors.

### Micronucleus test {#s2d3}

A bone marrow micronucleus test was carried out according to Schmid \[[@RRS077C13]\] with minor modifications \[[@RRS077C14]\]. Bone marrow smears prepared from both femurs were processed for the enumeration of micronucleated polychromatic erythrocytes (PCEs) and micronucleated normochromatic erythrocytes (NCEs). The slides were coded to avoid any observer bias. The micronuclei were scored using a light microscope at a magnification of 1000×. At least 5000 cells per mouse were counted, and the data for each experimental point were from at least five mice.

Statistical analysis {#s2e}
--------------------

Statistical evaluation of the data was done with the χ^2^ test and Student *t*-test, as appropriate. Statistical significance was assigned to *P* \< 0.05.

RESULTS {#s3}
=======

Verification of the adaptive response mouse model (Yonezawa Effect) {#s3a}
-------------------------------------------------------------------

Reproducibility of the Yonezawa Effect, the model for induction of AR in young adult female mice, was verified and confirmed by using low-LET X-rays for delivery of both the priming low dose at 0.50 Gy and challenge high dose at 7.50 Gy. The 30-day survival test was applied to evaluate the induction of AR (Fig. [1](#RRS077F1){ref-type="fig"}). Administration of the priming dose markedly increased the survival rate from 16.67% to 83.33%. Results clearly indicated that AR was induced with efficient reliability and reproducibility in our experimental setup. Serving also as a positive control, the verification work was performed in parallel with the following investigations using heavy ion irradiations as the challenge doses. Fig. 1.Effect of a priming dose of 0.50-Gy X-rays on a challenge dose of 7.50-Gy X-rays on 30-day survival of mice.The control group (solid line) received no irradiation, the 7.50-Gy X-rays group (broken line) received only the challenge irradiation, and the 0.50-Gy X-rays + 7.50-Gy X-rays (dotted line) received both the priming and the challenge irradiations. \*\*Indicates statistically significant differences (*P* \< 0.01) between the two groups that were compared.

Verification of previous *in vivo* adaptive response studies by the priming dose of 0.50 Gy X-rays against challenge doses from heavy ion irradiations {#s3b}
------------------------------------------------------------------------------------------------------------------------------------------------------

A rescue effect on bone marrow death in the 30-day survival test by the priming dose of 0.50 Gy X-rays against a challenge dose of 6.50 Gy from carbon ion irradiation or 5.50 Gy from neon ion irradiations was confirmed. Representative survival graphs showing that the priming low dose of X-rays could relieve the mouse killing effect caused by the challenge dose from carbon and neon ion irradiations are illustrated in Fig. [2](#RRS077F2){ref-type="fig"}A and B, respectively. In the following studies with carbon ion irradiations, a challenge dose of 5.75 Gy was used instead of 6.50 Gy to obtain more survivors in the 30-day survival test for further investigations of residual damage in the hematopoietic system. As shown in Fig. [2](#RRS077F2){ref-type="fig"}C, the challenge dose of 5.75 Gy alone resulted in mortality of 6.67%, whereas with a priming dose of 0.50 Gy from X-rays, no deaths occurred in the 30-day survival test. Fig. 2.Effect of a priming dose of 0.50-Gy X-rays on a challenge dose of 6.50-Gy carbon, 5.50-Gy neon or 5.75-Gy carbon on 30-day survival of mice.(**A**) The control group (solid line) received no irradiation, the 6.50-Gy carbon group (broken line) received only the challenge irradiation and the 0.50-Gy X-rays + 6.50-Gy carbon (dotted line) received both the priming and the challenge irradiations. (**B**) The control group (solid line) received no irradiation, the 5.50-Gy neon group (broken line) received only the challenge irradiation and the 0.50-Gy X-rays + 5.50-Gy neon (dotted line) received both the priming and the challenge irradiations. (**C**) The control group (solid line) received no irradiation, the 5.75-Gy carbon group (broken line) received only the challenge irradiation and the 0.50-Gy X-rays + 5.75 Gy carbon (dotted line) group received both the priming and the challenge irradiations. \*\*Indicates statistically significant differences (*P* \< 0.01) between the two groups that were compared.

Residual damage in bone marrow erythrocytes in the surviving animals {#s3c}
--------------------------------------------------------------------

Because bone marrow failure was the main cause of animal death in this AR mouse model, we measured residual damage in the bone marrow cells of surviving animals 1 day after the 30-day survival test. The ratio of PCEs to the to the sum of PCEs and NCEs is an indicator for bone marrow proliferation, and the micronucleus test is a tool for genotoxic assessment. Results obtained in surviving animals from the positive control group (receiving both priming and challenge doses from X-rays), the carbon ion group (receiving priming dose from X-rays and challenge dose from carbon ions), and the neon ion group (receiving priming dose from X-rays and challenge dose from neon ions) are shown in Fig. [3](#RRS077F3){ref-type="fig"}. The micronucleus test study showed that independently of the nature of the challenge dose (X-rays or heavy ion), the priming dose markedly improved the ratio of PCEs to the sum of PCEs and NCEs (Fig. [3](#RRS077F3){ref-type="fig"}A) and significantly reduced the occurrences of both micronucleated PCEs per 1000 PCEs (Fig. [3](#RRS077F3){ref-type="fig"}B) and micronucleated NCEs per 1000 NCEs (Fig. [3](#RRS077F3){ref-type="fig"}C) in the femur bone marrow when respectively compared with that receiving the challenge dose alone. Fig. 3.Effect of a priming dose of 0.50-Gy X-rays on a challenge dose of 7.50-Gy X-rays, 6.50-Gy carbon, 5.50-Gy neon or 5.75-Gy carbon on the femur bone marrow of mice.The percentage of polychromatic erythrocytes (PCEs) to PCEs and normochromatic erythrocytes (NCEs), the number of micronucleated PCEs (MNPCEs) per 1000 PCEs, and the number of micronucleated NCEs (MNNCEs) per 1000 NCEs are shown in **A**, **B** and **C**, respectively. \*Indicates statistically significant differences (*P* \< 0.05) between the two groups that were compared. \*\*Indicates statistically significant differences (*P* \< 0.01) between the two groups that were compared.

Residual damage in the peripheral blood hemogram in the surviving animals {#s3d}
-------------------------------------------------------------------------

Residual damage in the hematopoietic system was also studied in the peripheral blood hemogram in the surviving animals 1 day after the 30-day survival test. The priming dose of X-rays significantly reduced the decrease in peripheral blood platelet count induced by the challenge exposure (X-rays or heavy ion) (Fig. [4](#RRS077F4){ref-type="fig"}). Although a tendency for improved erythrocyte count and leukocyte count was observed in the surviving animals from each AR group compared with their counterparts that received only the challenge irradiation, no statistical significance was found (data not shown). These data indicated that the priming low dose of 0.50 Gy low-LET X-rays could relieve, to a certain extent, the detrimental effects from the challenge high dose from either low-LET X-rays or high-LET accelerated ion irradiations in the hematopoietic system. Fig. 4.Effect of a priming dose of 0.50-Gy X-rays on a challenge dose of 7.50-Gy X-rays, 6.50-Gy carbon, 5.50-Gy neon or 5.75-Gy carbon on the blood platelet count in the peripheral blood of mice. \*\*Indicates statistically significant differences (*P* \< 0.01) between the two groups that were compared.

DISCUSSION {#s4}
==========

To understand to what extent low-dose irradiations might be beneficial in humans, a better understanding of AR and other non-targeted effects is needed \[[@RRS077C15]\]. The 'Yonezawa Effect' summarized a series of studies on radiation-induced AR at whole-body level in mice. In a series of comprehensive investigations, Yonezawa and colleagues verified the existence of AR under a variety of experimental conditions (varying doses of priming and challenge irradiations, varying intervals between priming and challenge exposures, and varying age and strain of the experimental mice) \[[@RRS077C7]\]. These efforts helped to lay the cornerstone for an *in vivo* AR model in mice. Based on the priming dose and on the interval between priming and challenge exposures, two different phenotypes of AR were observed that involved different mechanisms: the first phenotype was induced 2 weeks after a 0.3--0.5-Gy priming irradiation and was due to Trp53-dependent radioresistance in blood-forming tissues \[[@RRS077C10], [@RRS077C16]\]; the second phenotype was observed 2 months after a 0.05--0.1-Gy priming exposure and resulted from the interaction between blood-forming tissue and the central nervous system \[[@RRS077C17], [@RRS077C18]\]. The model for the first phenotype was applied to the present study.

Low doses of low-LET irradiations induce protective effects through mechanisms such as enhancement of antioxidative capacities, increase in cellular DNA double-strand break repair capacity leading to reduction of initial DNA damage in AR in mice *in vivo* \[[@RRS077C19], [@RRS077C20]\], and reduction of cell death, chromosomal aberrations, mutations and malignant transformation *in vitro* \[[@RRS077C5], [@RRS077C21]\]. These induced responses have been tightly conserved throughout evolution, suggesting that they are basic responses critical to life \[[@RRS077C4]\]. In addition to the acute mouse killing effect in the AR animal model, examination of residual damage and late detrimental effects on the hematopoietic system, such as myelosuppression and delayed genotoxic effects, is of importance from the point of view of AR study and radiation protection. Well-designed animal experiments over extended periods of time have made studies on late effects possible. Because the biological effects produced by high-LET particulate irradiations were of some qualitative difference from those produced by low-LET photon exposures \[[@RRS077C22]\], the existence of AR induced by low-LET irradiations against high-LET irradiations provides new clues for mechanistic studies. In the present study, the residual damage in surviving animals was studied in the mouse AR model after the 30-day survival test. Induction of AR in mice was performed using X-rays as priming irradiations in combination with challenge irradiations from either X-rays or accelerated carbon or neon ions with LET values of about 15 and 30 keV/μm, respectively. Results showed that in the surviving animals rescued by AR, the ratio of PCEs to the sum of PCEs and NCEs was significantly higher and the incidences of micronucleated PCEs and micronucleated NCEs were markedly lower than those in the survivors that received only the challenge dose. These findings indicated that a priming low dose of X-rays at 0.5 Gy significantly relieved myelosuppression and reduced residual damage in bone marrow cells induced by the challenge irradiations. In addition, the priming low dose of X-rays also markedly improved the blood platelet count in the surviving mice. Our blood platelet count results were consistent with previous results showing that rescue from bone marrow death was mainly due to priming irradiation-induced radio-resistance to challenge irradiation-induced Trp53-dependent apoptosis in hematopoietic stem cells \[[@RRS077C16], [@RRS077C23]\] and that the recovery of blood platelet count after exposure was one of the most important factors for restoration from bone marrow death \[[@RRS077C24]\]. The results of blood platelet counts obtained in the present study were consistent with these previous studies.

The recovery ratio from potentially lethal damage is known to depend on the quality of radiation \[[@RRS077C25]\]; cellular radio-sensitivity correlates with the frequency of residual chromatin breaks \[[@RRS077C26]\], and high-LET irradiations have been shown to induce higher rates of residual chromatin breaks \[[@RRS077C27]\]. Although high-LET heavy ions generally induce qualitatively different DNA damage (such as clustered DNA damage) in comparison with that of low-LET irradiations, the results of the present study suggested that the X-ray-induced biological defense mechanisms may be considered as effective countermeasures, being sufficient enough against the damage caused by high-LET challenge doses. In fact, mechanistic studies using cultured human fibroblasts reported that gene expression profiles following gamma radiation and decays of high-LET-like ^125^I shared the majority of genes in common, indicating that both kinds of radiation elicited similar signal transduction pathways \[[@RRS077C28]\]; thus, DNA double-strand breaks may not be the major factor modulating changes in gene expression following irradiation \[[@RRS077C29]\]. *In vitro* studies also showed that low doses of low-LET X-ray irradiations were effective in reducing chromosomal aberrations and mutation frequency induced by high-LET irradiations \[[@RRS077C21], [@RRS077C30]\]. These findings suggest that it may share at least to a large extent the same mechanisms against the damage caused by the high dose of challenge irradiations from low-LET X-rays and high-LET heavy ions.

Taken together, our results showed that a priming low dose of low-LET irradiations could relieve detrimental late effects (anhematopoiesis and delayed genotoxic effects) occurring in bone marrow cells. Results indicated the significance and possible application of AR to the reduction of genomic instability induced by high-dose irradiations from either low- or high-LET irradiations. These findings give new knowledge of the characterization of the 'Yonezawa Effect' by providing new insight into the mechanistic study of low-LET X-ray-induced AR against the detrimental effects of high-LET accelerated heavy ions in the mouse model of AR *in vivo*.
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